Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Euro Surveill ; 22(1)2017 Jan 05.
Artigo em Inglês | MEDLINE | ID: mdl-28080959

RESUMO

We describe the epidemiological pattern and genetic characteristics of 242 acute dengue infections imported to Europe by returning travellers from 2012 to 2014. The overall geographical pattern of imported dengue (South-east Asia > Americas > western Pacific region > Africa) remained stable compared with 1999 to 2010. We isolated the majority of dengue virus genotypes and epidemic lineages causing outbreaks and epidemics in Asia, America and Africa during the study period. Travellers acted as sentinels for four unusual dengue outbreaks (Madeira, 2012-13; Luanda, 2013; Dar es Salaam, 2014; Tokyo, 2014). We were able to characterise dengue viruses imported from regions where currently no virological surveillance data are available. Up to 36% of travellers infected with dengue while travelling returned during the acute phase of the infection (up to 7 days after symptom onset) or became symptomatic after returning to Europe, and 58% of the patients with acute dengue infection were viraemic when seeking medical care. Epidemiological and virological data from dengue-infected international travellers can add an important layer to global surveillance efforts. A considerable number of dengue-infected travellers are viraemic after arrival back home, which poses a risk for dengue introduction and autochthonous transmission in European regions where suitable mosquito vectors are prevalent.


Assuntos
Vírus da Dengue/isolamento & purificação , Dengue/epidemiologia , Dengue/transmissão , Surtos de Doenças , Vigilância de Evento Sentinela , Viagem , África/epidemiologia , América/epidemiologia , Sudeste Asiático/epidemiologia , Dengue/diagnóstico , Vírus da Dengue/genética , Europa (Continente)/epidemiologia , Genótipo , Humanos , Incidência , Filogenia , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Medicina de Viagem/métodos
2.
Invest New Drugs ; 31(5): 1107-14, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23912257

RESUMO

Introduction Uveal melanoma (UM) is a highly vascularised tumour generally treated with radiotherapy (RT). A recent preclinical study from our group [1] demonstrated that RT-associated anti-angiogenic therapy has more than additive effects on cell growth, by modulating vascular endothelial growth factor (VEGF) levels. The pro-angiogenic interleukin-8 (IL-8) is highly expressed in both tumour and endothelial cells and is associated with resistance to VEGF-targeted therapies in various tumour types. The aim of this study is to investigate IL-8 release in response to the anti-angiogenic drug bevacizumab (AV) and RT given alone and in combination. Material and methods The human ocular melanoma cells (OCM-1) and human umbilical vein endothelial cells (HUVEC) were grown in transwell plates. AV was administered at a 2,500 µg/ml dose and cells were irradiated with a 6 Gy dose. IL-8 concentrations were determined by ELISA assay. Protein expression was detected by western blot. Results AV alone or in combination with RT reduces VEGF levels in both cell lines when co-cultured; unexpectedly, RT alone did not increase VEGF levels. In transwell plate AV alone lowered IL-8 secretion in both cell lines. This inhibitory effect was reduced when co-cultured cells are treated with AV + RT, suggesting that RT-induced VEGF may reactivate IL-8 secretion, enhancing an alternative pathway to sustain tumour angiogenesis. Conclusions These data indicate that the UM microenvironment, beside VEGF, can activate IL-8 signalling as an alternative pro-angiogenic pathway.


Assuntos
Inibidores da Angiogênese/farmacologia , Anticorpos Monoclonais Humanizados/farmacologia , Interleucina-8/metabolismo , Melanoma/metabolismo , Neovascularização Patológica/metabolismo , Neoplasias Uveais/metabolismo , Bevacizumab , Linhagem Celular Tumoral , Células Cultivadas , Técnicas de Cocultura , Terapia Combinada , Células Endoteliais da Veia Umbilical Humana/efeitos dos fármacos , Células Endoteliais da Veia Umbilical Humana/metabolismo , Humanos , Melanoma/tratamento farmacológico , Melanoma/patologia , Melanoma/radioterapia , Neovascularização Patológica/tratamento farmacológico , Neovascularização Patológica/radioterapia , Receptores de Interleucina-8B/metabolismo , Neoplasias Uveais/tratamento farmacológico , Neoplasias Uveais/patologia , Neoplasias Uveais/radioterapia , Fator A de Crescimento do Endotélio Vascular/metabolismo
3.
J Travel Med ; 22(5): 341-4, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26080943

RESUMO

Chikungunya virus (CHIKV) has recently emerged in the Caribbean. In Italy, CHIKV vector is documented in the Po river valley; therefore, a risk for autochthonous outbreaks is present. We report a case series of seven imported CHIKV infections in travelers returning from the Caribbean and Latin America occurring between June and November 2014, in the area of Turin, Northwest Italy, 3 years after the last imported cases were reported. These cases are a reminder of the need to always consider CHIKV infection in travelers from these epidemic areas as well as the importance of a prompt diagnosis.


Assuntos
Febre de Chikungunya/diagnóstico , Vírus Chikungunya/isolamento & purificação , Insetos Vetores/virologia , Viagem/estatística & dados numéricos , Clima Tropical , Aedes/virologia , Animais , Região do Caribe , Febre de Chikungunya/prevenção & controle , Surtos de Doenças/prevenção & controle , Humanos , Itália , América Latina , Fatores de Risco , Estações do Ano
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA